BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16460830)

  • 1. Loading and mobility of spin-labeled insulin in physiologically responsive complexation hydrogels intended for oral administration.
    Besheer A; Wood KM; Peppas NA; Mäder K
    J Control Release; 2006 Mar; 111(1-2):73-80. PubMed ID: 16460830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery.
    Kumar A; Lahiri SS; Singh H
    Int J Pharm; 2006 Oct; 323(1-2):117-24. PubMed ID: 16828246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin.
    Sajeesh S; Bouchemal K; Marsaud V; Vauthier C; Sharma CP
    J Control Release; 2010 Nov; 147(3):377-84. PubMed ID: 20727924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complexation hydrogels for oral insulin delivery: effects of polymer dosing on in vivo efficacy.
    Tuesca A; Nakamura K; Morishita M; Joseph J; Peppas N; Lowman A
    J Pharm Sci; 2008 Jul; 97(7):2607-18. PubMed ID: 17876768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproteolytic action of orally delivered insulin using pH-responsive hydrogels in a rat burn model.
    Madihally SV; Pantelogianis A; Toner M
    J Surg Res; 2006 Sep; 135(1):187-94. PubMed ID: 16616764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel delivery system based on complexation hydrogels as delivery vehicles for insulin-transferrin conjugates.
    Kavimandan NJ; Losi E; Peppas NA
    Biomaterials; 2006 Jul; 27(20):3846-54. PubMed ID: 16529810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics.
    Nakamura K; Murray RJ; Joseph JI; Peppas NA; Morishita M; Lowman AM
    J Control Release; 2004 Mar; 95(3):589-99. PubMed ID: 15023469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel polyelectrolyte complexes based on poly(methacrylic acid)-bis(2-aminopropyl)poly(ethylene glycol) for oral protein delivery.
    Sajeesh S; Sharma CP
    J Biomater Sci Polym Ed; 2007; 18(9):1125-39. PubMed ID: 17931503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complexation hydrogels for oral protein delivery: an in vitro assessment of the insulin transport-enhancing effects following dissolution in simulated digestive fluids.
    Perakslis E; Tuesca A; Lowman A
    J Biomater Sci Polym Ed; 2007; 18(12):1475-90. PubMed ID: 17988515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of thermosensitive chitosan-based hydrogels by rheology and electron paramagnetic resonance spectroscopy.
    Kempe S; Metz H; Bastrop M; Hvilsom A; Contri RV; Mäder K
    Eur J Pharm Biopharm; 2008 Jan; 68(1):26-33. PubMed ID: 17870449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The characteristics of spontaneously forming physically cross-linked hydrogels composed of two water-soluble phospholipid polymers for oral drug delivery carrier I: hydrogel dissolution and insulin release under neutral pH condition.
    Nam K; Watanabe J; Ishihara K
    Eur J Pharm Sci; 2004 Nov; 23(3):261-70. PubMed ID: 15489127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination Strategy with Complexation Hydrogels and Cell-Penetrating Peptides for Oral Delivery of Insulin.
    Fukuoka Y; Khafagy ES; Goto T; Kamei N; Takayama K; Peppas NA; Takeda-Morishita M
    Biol Pharm Bull; 2018; 41(5):811-814. PubMed ID: 29709919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption.
    Morishita M; Goto T; Peppas NA; Joseph JI; Torjman MC; Munsick C; Nakamura K; Yamagata T; Takayama K; Lowman AM
    J Control Release; 2004 May; 97(1):115-24. PubMed ID: 15147809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly methacrylic acid-alginate semi-IPN microparticles for oral delivery of insulin: a preliminary investigation.
    Sajeesh S; Sharma CP
    J Biomater Appl; 2004 Jul; 19(1):35-45. PubMed ID: 15245642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential use of gamma-cyclodextrin polypseudorotaxane hydrogels as an injectable sustained release system for insulin.
    Abu Hashim II; Higashi T; Anno T; Motoyama K; Abd-ElGawad AE; El-Shabouri MH; Borg TM; Arima H
    Int J Pharm; 2010 Jun; 392(1-2):83-91. PubMed ID: 20298768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel biodegradable and pH-sensitive poly(ester amide) microspheres for oral insulin delivery.
    He P; Tang Z; Lin L; Deng M; Pang X; Zhuang X; Chen X
    Macromol Biosci; 2012 Apr; 12(4):547-56. PubMed ID: 22362708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Starch-based polymeric carriers for oral-insulin delivery.
    Mahkam M
    J Biomed Mater Res A; 2010 Mar; 92(4):1392-7. PubMed ID: 19353572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral delivery of insulin using pH-responsive complexation gels.
    Lowman AM; Morishita M; Kajita M; Nagai T; Peppas NA
    J Pharm Sci; 1999 Sep; 88(9):933-7. PubMed ID: 10479357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery.
    Sajeesh S; Sharma CP
    Int J Pharm; 2006 Nov; 325(1-2):147-54. PubMed ID: 16859846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterization and in vivo efficacy of PEGylated insulin for oral delivery with complexation hydrogels.
    Tuesca AD; Reiff C; Joseph JI; Lowman AM
    Pharm Res; 2009 Mar; 26(3):727-39. PubMed ID: 19145407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.